---
import BaseLayout from '../../layouts/BaseLayout.astro';
import MedicalDisclaimer from '../../components/MedicalDisclaimer.astro';

const affiliateLinks = { medvi: 'https://medvi.org/?page=multi&uid=5&oid=2&affid=2&pol=5&sub1=1350&sub1=1350&oid2=4412&affid2=1350' };
---

<BaseLayout 
  title="Retatrutide vs Wegovy (Semaglutide): Which Weight Loss Medication Is Better?"
  description="Retatrutide (24-28.7% weight loss) vs Wegovy (10-15%). Compare effectiveness, cost, side effects, and which one you should choose."
>
  <style>
    .hero { background: linear-gradient(135deg, #f97316 0%, #ea580c 100%); color: white; padding: 80px 24px 60px; text-align: center; }
    .hero h1 { font-size: clamp(2rem, 5vw, 2.8rem); font-weight: 700; margin-bottom: 16px; line-height: 1.2; }
    .content { max-width: 900px; margin: 0 auto; padding: 60px 24px 120px; }
    .content h2 { font-size: 2rem; font-weight: 700; margin: 48px 0 16px; }
    .content p { font-size: 1.05rem; line-height: 1.7; color: #4b5563; margin-bottom: 20px; }
    .content ul { margin: 20px 0; padding-left: 24px; }
    .content li { font-size: 1.05rem; line-height: 1.7; color: #4b5563; margin-bottom: 12px; }
    .content table { width: 100%; border-collapse: collapse; margin: 24px 0; }
    .content th { background: #f9fafb; padding: 12px; text-align: left; border-bottom: 2px solid #e5e7eb; }
    .content td { padding: 12px; border-bottom: 1px solid #e5e7eb; }
  </style>

  <div class="hero">
    <h1>Retatrutide vs Wegovy: Head-to-Head Comparison</h1>
    <p>Triple agonist retatrutide vs single agonist Wegovy (semaglutide). Which delivers better weight loss?</p>
  </div>

  <div class="content">
    <h2>Quick Comparison</h2>
    <table>
      <thead>
        <tr>
          <th>Feature</th>
          <th>Retatrutide</th>
          <th>Wegovy</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td><strong>Weight Loss</strong></td>
          <td>24-28.7%</td>
          <td>10-15%</td>
        </tr>
        <tr>
          <td><strong>Mechanism</strong></td>
          <td>Triple agonist</td>
          <td>Single agonist (GLP-1)</td>
        </tr>
        <tr>
          <td><strong>Availability</strong></td>
          <td>2027-2028</td>
          <td>Available now</td>
        </tr>
        <tr>
          <td><strong>Brand Cost</strong></td>
          <td>$900-1,400/mo (est)</td>
          <td>$900-1,400/mo</td>
        </tr>
        <tr>
          <td><strong>Compounded Cost</strong></td>
          <td>Unknown</td>
          <td>$179-349/mo</td>
        </tr>
      </tbody>
    </table>

    <h2>Weight Loss: Retatrutide Wins</h2>
    <p><strong>Retatrutide:</strong> 24-28.7% average weight loss (up to 71 lbs for a 240-lb person)</p>
    <p><strong>Wegovy:</strong> 14.9% average weight loss (~36 lbs for a 240-lb person)</p>

    <p><strong>Retatrutide delivers nearly DOUBLE the weight loss</strong> due to its triple-agonist mechanism.</p>

    <h2>Availability: Wegovy Wins</h2>
    <p><strong>Wegovy is available NOW:</strong></p>
    <ul>
      <li>FDA approved since 2021</li>
      <li>$179-349/month through compounded semaglutide</li>
      <li>Can start today through telemedicine</li>
      <li>5+ years of real-world safety data</li>
    </ul>

    <p><strong>Retatrutide is 1-2 years away:</strong></p>
    <ul>
      <li>Still in Phase 3 clinical trials</li>
      <li>Expected FDA approval 2027-2028</li>
      <li>Only available through clinical trials currently</li>
      <li>Limited real-world safety data</li>
    </ul>

    <h2>Side Effects: Similar</h2>
    <p>Both medications share GI side effects due to GLP-1 activation:</p>
    <ul>
      <li>Nausea (most common)</li>
      <li>Diarrhea or constipation</li>
      <li>Vomiting</li>
      <li>Reduced appetite</li>
    </ul>

    <p><strong>Wegovy advantage:</strong> More real-world data means we know exactly what to expect. Retatrutide is newer with less long-term safety information.</p>

    <h2>Cost: Wegovy Wins (Compounded)</h2>
    <p><strong>Wegovy brand-name:</strong> $900-1,400/month without insurance</p>
    <p><strong>Compounded semaglutide:</strong> $179-349/month through telemedicine (available NOW)</p>

    <p><strong>Retatrutide pricing:</strong> Unknown but expected to match Wegovy brand pricing. Compounded availability uncertain.</p>

    <h2>Which Should You Choose?</h2>

    <h3>Choose Retatrutide If:</h3>
    <ul>
      <li>You can wait 1-2 years for FDA approval</li>
      <li>You need maximum weight loss (75+ pounds)</li>
      <li>You've tried Wegovy and plateaued</li>
      <li>Cost isn't a primary concern</li>
    </ul>

    <h3>Choose Wegovy/Semaglutide If:</h3>
    <ul>
      <li>You want to start losing weight TODAY</li>
      <li>You want the most affordable option ($179-349/mo)</li>
      <li>You prefer medications with long safety track records</li>
      <li>You need 25-40 pounds of weight loss</li>
    </ul>

    <h2>The Practical Answer</h2>
    <p><strong>Start Wegovy (compounded semaglutide) NOW:</strong></p>
    <ul>
      <li>Lose 30-40 pounds in the next 12-18 months</li>
      <li>Only $179-349/month through telemedicine</li>
      <li>Available today, ships in 3-5 days</li>
      <li>Switch to retatrutide in 2027-2028 if you plateau</li>
    </ul>

    <p><strong>Why wait?</strong> You'll be healthier NOW instead of staying overweight until 2028. You can always switch medications later.</p>

    <div style="background: linear-gradient(135deg, #10b981 0%, #059669 100%); color: white; border-radius: 12px; padding: 40px 32px; text-align: center; margin: 48px 0;">
      <h3 style="font-size: 1.8rem; font-weight: 700; margin-bottom: 12px;">Start Semaglutide (Wegovy Alternative) for $179/Month</h3>
      <p style="font-size: 1.05rem; opacity: 0.95; margin-bottom: 24px;">Same active ingredient as Wegovy. Available now through telemedicine.</p>
      <a href={affiliateLinks.medvi} target="_blank" rel="noopener sponsored" style="background: white; color: #059669; padding: 14px 28px; border-radius: 8px; font-weight: 700; text-decoration: none; display: inline-block;">Start with MEDVi â†’</a>
    </div>

    <p><strong>Related:</strong> <a href="/peptides/retatrutide-vs-tirzepatide" style="color: #f97316;">Retatrutide vs Tirzepatide</a> | <a href="/peptides/retatrutide" style="color: #f97316;">What Is Retatrutide?</a></p>

    <MedicalDisclaimer />
  </div>
</BaseLayout>
